Nieuws

EASD 2019

Twitter

Interessant congres! 'Maternal obesity and pre-eclampsia: common pathways', 5-6 november 2019, Amsterdam. Meer informatie: https://t.co/ueOJcwyNkx ... @WorldObesity @BiochemSoc

Hoe breng jij de diabetes- en vasculaire standaarden in de praktijk? Onze geaccrediteerde nascholingen voor huisartsen en praktijkondersteuners bieden... handreikingen en inspiratie. In Rotterdam, Eindhoven, Amsterdam, Emmen en nog 16 andere locaties. https://t.co/lR3jp77eB0

Hypoglycaemia is a serious complication of diabetes characterised by low blood sugar levels. The @HypoResolve project is tackling the problem and its ... impact on the lives of people with diabetes and their carers: https://t.co/yNtXE0NPqW

During #EASD2019 we had the opportunity to speak with Prof. Chantal Mathieu about EASD's growing e-Learning platform (which you can access for free at... https://t.co/1y9truafzc) #diabetes #education #elearning

There is a wide distribution in lifetime gain and harm from adding low-dose rivaroxaban to aspirin in patients with stable CVD. Using lifetime models,... benefits and bleeding risk can be weighed for individual patients. #Cardiovascular #Epidemiology @UMCUtrecht @Juliuscenter